ATI-1013

· Antidote Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-1013, covering 2025-10-15 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers [Phase 1]